| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |